Emtricitabine Oral Solution — FDA Drug Shortage
The FDA lists a drug shortage record for Emtricitabine Oral Solution (oral solution) from Gilead Sciences, Inc. with status To Be Discontinued. The shortage was first posted on Jun 17, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Gilead Sciences, Inc.
- Package NDC
- 61958-0602-1
- Dosage Form
- Oral Solution
- Presentation
- Emtriva, Oral Solution, 10 mg/1 mL (NDC 61958-0602-1)
- Initial Posting
- Jun 17, 2026